Overview

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the rate of response and the duration of the response following therapy with Aroplatinin patients with advanced solid malignancies.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Aronex Pharmaceuticals
Treatments:
bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)